임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 3상모집 중단 (진행 중)· Moderately to Severely Active Ulcerative ColitisA Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
리드: 로슈
- 3상모집 중단 (진행 중)· Thyroid Eye DiseaseA Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease
리드: 로슈
- 3상모집 중단 (진행 중)· Thyroid Eye DiseaseStudy to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease
리드: 로슈
- 3상모집 중단 (진행 중)· Breast CancerA Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
리드: 로슈
- 3상모집 중단 (진행 중)· Childhood Idiopathic Nephrotic SyndromeA Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome
리드: 로슈
- 3상모집 중단 (진행 중)· Chronic Obstructive Pulmonary Disease (COPD)A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
리드: 로슈
- 3상모집 중단 (진행 중)· Non-Small Cell Lung CancerA Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)
리드: 로슈
- 3상모집 중단 (진행 중)· Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
리드: 로슈
- 3상모집 중단 (진행 중)· Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerA Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)
리드: 로슈
- 3상모집 중단 (진행 중)· Locally Advanced or Metastatic Breast CancerA Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)
리드: 로슈
- 3상모집 중단 (진행 중)· Non-Small Cell Lung CancerA Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer
리드: 로슈
- 3상모집 중단 (진행 중)· Relapsing-remitting Multiple SclerosisA Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)
리드: 로슈
- 3상모집 중단 (진행 중)· Multiple SclerosisA Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
리드: 로슈
- 3상모집 중단 (진행 중)· Atypical Hemolytic Uremic SyndromeA Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
리드: 로슈
- 3상모집 중단 (진행 중)· Relapsed or Refractory Follicular LymphomaA Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma
리드: 로슈
- 3상모집 중단 (진행 중)· Systemic Lupus ErythematosusA Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus
리드: 로슈
- 3상모집 중단 (진행 중)· Atypical Hemolytic Uremic SyndromeA Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
리드: 로슈
- 3상모집 중단 (진행 중)· Neovascular Age-related Macular Degeneration (nAMD)A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)
리드: 로슈
- 3상모집 중단 (진행 중)· Primary Membranous NephropathyA Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy
리드: 로슈
- 3상모집 중단 (진행 중)· Muscle-invasive Bladder CancerA Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following Cystectomy
리드: 로슈
- 3상모집 중단 (진행 중)· Unresectable Hepatocellular CarcinomaA Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
리드: 로슈
- 3상모집 중단 (진행 중)· Relapsing Multiple SclerosisStudy to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
리드: 로슈
- 3상모집 중단 (진행 중)· Relapsing Multiple SclerosisA Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
리드: 로슈
- 3상모집 중단 (진행 중)· Paroxysmal Nocturnal HemoglobinuriaA Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibition
리드: 로슈
- 3상모집 중단 (진행 중)· Hepatocellular CarcinomaA Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma
리드: 로슈
- 3상모집 중단 (진행 중)· Chronic Lymphoid LeukemiaIbrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)
협력: 애브비, 얀센(J&J), 로슈
- 3상모집 중단 (진행 중)· Small Cell Lung CarcinomaStudy of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer
리드: 로슈
- 3상모집 중단 (진행 중)· Multiple Sclerosis, Primary ProgressiveA Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
리드: 로슈
- 3상모집 중단 (진행 중)· Metastatic Prostate CancerStudy of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC
협력: 로슈, 다케다
- 3상모집 중단 (진행 중)· Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerA Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)
리드: 로슈
- 3상모집 중단 (진행 중)· Paroxysmal Nocturnal HemoglobinuriaA Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors
리드: 로슈
- 3상모집 중단 (진행 중)· Paroxysmal Nocturnal HemoglobinuriaA Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors
리드: 로슈
- 3상모집 중단 (진행 중)· Esophageal Squamous Cell CarcinomaA Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
리드: 로슈
- 3상모집 중단 (진행 중)· Myelodysplastic Syndrome (MDS)Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
리드: 애브비 · 협력: 로슈
- 3상모집 중단 (진행 중)· Lupus NephritisA Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis
리드: 로슈
- 3상모집 중단 (진행 중)· Diabetic Macular EdemaA Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME
리드: 로슈
- 3상모집 중단 (진행 중)· Multiple Sclerosis, Primary ProgressiveA Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
리드: 로슈
- 3상모집 중단 (진행 중)· Bladder CancerAtezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Patients
협력: 로슈
- 3상모집 중단 (진행 중)· Invasive Breast CancerNeoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer
협력: 로슈
- 3상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungA Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer
리드: 로슈
- 3상모집 중단 (진행 중)· Progressive Multiple Sclerosis (PMS)A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
리드: 로슈
- 3상모집 중단 (진행 중)· Triple Negative Breast CancerClinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
협력: 로슈
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.